According to the World Health Organization (WHO), over 422 million people globally live with diabetes, while obesity has nearly tripled since 1975, with more than 1 billion individuals affected, significantly increasing demand for effective GLP-1-based therapeutic interventions worldwide
Common questions How do I taper off 0.25 mg of Semaglutide
The decision should be made collaboratively with your prescriber based on your individual circumstances, steroid dose, and treatment goals
Kaelberer MM, Rupprecht LE, Liu WW, Weng P, Bohrquez DV
If you are considering GLP-1 agonists for weight loss, it is important to consult with a healthcare professional who can provide accurate information and help you determine if this treatment is right for you